1 Product identity
Ingredient risk
Contains a high-risk ingredient
Choline-Inositol Complex 500 mg / 500 mg With Pantothenic Acid
BrandCountry Life→Other Combinations Tablet or Pill 11 ingredients 1 high-risk 1 caution DSLD #14222Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2012-10-25
2 Ingredients (11)
IngredientGroupSafety
CelluloseCellulose—
Stearic AcidStearic Acid—
Cellulose & Glycerin CoatingCoating—
VanillaVanilla—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ High-risk ingredient — documented serious harm
Inositol — GDM prevention — 4 g/day from first trimester in high-risk women [2]
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Pantothenic Acid — Limited Evidence
⚠ Diarrhea at very high doses
Inositol — High risk
⚠ GI disturbance at high doses (>12 g)
⚠ May lower blood glucose
Choline — Generally Safe
⚠ Fishy odor at high doses
Silicon — Generally Safe
⚠ Very low toxicity
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
GLA — Limited Evidence
⚠ May lower seizure threshold
⚠ Borage oil: hepatotoxic unless PA-free
4 Label claims
• All Other
5 Data source
DSLD ID14222
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-10-25
6 More from Country Life
View Country Life Safety Scorecard → 199 products
7-KetoTrimAcetyl L-Carnitine Caps 500 mgAcid Rescue Mint FlavorAcidophilus With PectinAction Max For MenAction Max For Men7 Cite this page
Vancouver
Pkhakadze G. Choline-Inositol Complex 500 mg / 500 mg With Pantothenic Acid — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 25]. Available from: https://supplement.ge/products/choline-inositol-complex-500-mg-500-mg-with-pantothenic-acid-14222/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG